首站-论文投稿智能助手
典型文献
Severe Type of COVID-19:Pathogenesis,Warning Indicators and Treatment
文献摘要:
Coronavirus disease 2019 (COVID-19),caused by severe acute respiratory syndrome coronavirus 2,is a major public health issue.The epidemic is unlikely to be contained until the global launch of safe and effective vaccines that could prevent serious illnesses and provide herd immunity.Although most patients have mild flu-like symptoms,some develop severe illnesses accompanied by multiple organ dysfunction.The identification of pathophysiology and early waming biomarkers of a severe type of COVID-19 contribute to the treatment and prevention of serious complications.Here,we review the pathophysiology,early warning indicators,and effective treatment of Chinese and Westem Medicine for patients with a severe type of COVID-19.
文献关键词:
作者姓名:
SHI Ke;LIU Yao;ZHANG Qun;RAN Chong-ping;HOU Jie;ZHANG Yi;WANG Xian-bo
作者机构:
Center of Integrative Medicine,Beijing Ditan Hospital,Capital Medical University,Beijing 100015 ,China;Department of Gastroenterology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100007 ,China
引用格式:
[1]SHI Ke;LIU Yao;ZHANG Qun;RAN Chong-ping;HOU Jie;ZHANG Yi;WANG Xian-bo-.Severe Type of COVID-19:Pathogenesis,Warning Indicators and Treatment)[J].中国结合医学杂志(英文版),2022(01):3-11
A类:
waming
B类:
Severe,Type,Pathogenesis,Warning,Indicators,Treatment,Coronavirus,disease,caused,by,severe,acute,respiratory,syndrome,coronavirus,major,public,health,issue,epidemic,unlikely,be,contained,until,global,launch,safe,effective,vaccines,that,could,serious,illnesses,provide,herd,immunity,Although,most,patients,have,mild,flu,symptoms,some,develop,accompanied,multiple,organ,dysfunction,identification,pathophysiology,early,biomarkers,type,contribute,treatment,prevention,complications,Here,we,review,warning,indicators,Chinese,Westem,Medicine
AB值:
0.70524
相似文献
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Tongue and pulse features of 668 asymptomatic patients infected with the severe acute respiratory syndrome coronavirus 2 omicron variant in Shanghai
ZHANG Wen;CAO Min;SUN Ding;SHI Li;LU Wei;XU Xiangru;ZHOU Shuang;FANG Bangjiang-Department of Emergency,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Rheumatology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Pediatrics,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Nursing,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;College of Acumox and Tuina,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Institute of Emergency and Critical Care Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
Highly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients
Zhang Wenyan;Liu Wei;Lin Jiawang;Jin Jing;Zhao Kefu;Zhu Liwei;Wang Xiuzhen;Wang Lijie;Tang Renshu;Zhu Yindi;Zhou Wei;You Enqing;Zhang Lei;Liu Xuxiang;Wu Jinju;Chen Lili;Wang Wenjing;Zhang Qiang;Gao Rongbao-Hefei Center for Disease Control and Prevention, Hefei, Anhui Province 230061, China;BIOHIT Healthcare (Hefei) Co., Hefei, Anhui Province 230000, China;The First People’s Hospital of Hefei, Hefei, Anhui Province 230091, China;Anhui Provincial Hospital, Hefei, Anhui Province 231501, China;State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Factors Predicting Progression to Severe COVID-19:A Competing Risk Survival Analysis of 1753 Patients in Community Isolation in Wuhan,China
Simiao Chen;Hui Sun;Mei Heng;Xunliang Tong;Pascal Geldsetzer;Zhuoran Wang;Peixin Wu;Juntao Yang;Yu Hu;Chen Wang;Till B?rnighausen-Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China;Heidelberg Institute of Global Health(HIGH),Faculty of Medicine and University Hospital,Heidelberg University,Heidelberg 69120,Germany;Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Pulmonary and Critical Care Medicine,Beijing Hospital,Beijing 100730,China;National Center of Gerontology,Institute of Geriatric Medicine,Beijing 100730,China;Division of Primary Care and Population Health,Department of Medicine,Stanford University,Stanford,CA 94305,USA;Peking Union Medical College Hospital,Beijing 100730,China;State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China;National Clinical Research Center for Respiratory Diseases,Beijing 100029,China;Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China
Potential Treatment of COVID-19 with Traditional Chinese Medicine:What Herbs Can Help Win the Battle with SARS-CoV-2?
Lin Li;Yuzheng Wu;Jiabao Wang;Huimin Yan;Jia Lu;Yu Wang;Boli Zhang;Junhua Zhang;Jian Yang;Xiaoying Wang;Min Zhang;Yue Li;Lin Miao;Han Zhang-State Key Laboratory of Component-Based Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae,Ministry of Education,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;School of Integrative Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Evidence-Based Medicine Center,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;College of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China
Progression of the Wei?Qi?Ying?Xue Syndrome, Microcirculatory Disturbances, in Infectious Diseases and Treatment with Traditional Chinese Medicine
Jing?Yan Han;Quan Li;Chun?Shui Pan;Kai Sun;Jing?Yu Fan-Department of Integration of Chinese and Western Medicine,School of Basic Medical Sciences,Peking University,Beijing,People's Republic of China;Academy of Integration of Chinese and Western Medicine,Peking University Health Science Center,Beijing,People's Republic of China;Tasly Microcirculation Research Center,Peking University Health Science Center,Beijing,People's Republic of China;Department of Integration of Chinese and Western Medicine,Peking University,Key Laboratory of Stasis and Phlegm,State Administration of Traditional Chinese Medicine of the People's Republic of China,Beijing,People's Republic of China;Department of Integration of Chinese and Western Medicine,Peking University,Beijing Laboratory of Integrative Microangiopathy,Beijing,People's Republic of China;Department of Integration of Chinese and Western Medicine,Peking University,State Key Laboratory of Core Technology in Innovative Chinese Medicine,Beijing,People's Republic of China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。